Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study).

DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Primary tabs

Swimberghe, Sandra Ghislain, Pierre-Dominique [UCL] Daci, Evis Allewaert, Katrien Denhaerynck, Kris Abraham, Ivo et al.[show all]

Apart from clinical outcomes, the "real-world" outcomes of intermittent short-course cyclosporine treatment remain poorly documented.

Document type	Article de périodique (Journal article)
Access type	Accès restreint
Publication date	2013
Language	Anglais
Journal information	"Annals of Dermatology" - Vol. 25, no.1, p. 28 (2013)
Publisher	Taehan P'ibu Kwahakhoe
issn	1013-9087
e-issn	2005-3894
Affiliation	UCL - (SLuc) Service de dermatologie
Links	http://www.ncbi.nlm.nih.gov/pubmed/23467644[Pubmed] http://hdl.handle.net/2078.1/157506[Handle] https://doi.org/10.5021/ad.2013.25.1.28[DOI]

Bibliographic reference	Swimberghe, Sandra ; Ghislain, Pierre-Dominique ; Daci, Evis ; Allewaert, Katrien ; Denhaerynck, Kris ; et. al. Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study).. In: Annals of Dermatology, Vol. 25, no.1, p. 28 (2013)
Permanent URL	http://hdl.handle.net/2078.1/157506